EVER Pharma
About EVER Pharma
Certifications
-
GMP
Categories
-
AT -
2015On CPHI since
-
2Certificates
-
1000 - 4999Employees
Company types
Primary activities
Contact info
-
-
-
Oberburgau 3, 4866 , Unterach, Austria
Meet us at
CPHI Milan 2024
Fiera Milano, Italy
08 Oct 2024 - 10 Oct 2024
Products from EVER Pharma (13)
-
Product Atosiban
Atosiban is an inhibitor of the hormones oxytocin and vasopressin. It is used as an intravenous medication as a labour repressant (tocolytic) to halt premature labour. Atosiban EVER is indicated to delay imminent pre-term birth in pregnant adult women with a gestational age from 24 until 33 completed weeks... -
Product Cabazitaxel EVER Pharma: 45mg/4.5ml + 50mg/5ml + 60mg/60ml - Single liquid vial
Cabazitaxel EVER Pharma is provided as a single vial, ready to dilute formulation and is available in vial sizes covering the common range of patient specifi c doses for economy and convenience Cabazitaxel is a third-generation antineoplastic taxane and was the fi rst therapy to show a survival benefi t f... -
Product Contract Manufacturing
EVER Pharma is a specialist in the manufacture of complex injectable products such as low oxygen formulations, crystal suspensions and oily solutions. This includes many highly active substances such as narcotics, hormones and cytotoxics.
Our state-of-the-art facility utilizes the latest innovations i... -
Product EVER Pharma Product List
Our products include: • Atosiban • Cabazitaxel • Cebrium® • Cerebrolysin® • Dacepton® • Dexmedetomidine • Docetaxel • Fulvestrant • MemoProve® • Oxytocin • Paclitaxel • Pemetrexed • Tachyben® • Terlipressin -
Product EVER Pharma: Product Portfolio
Our products include: Atosiban, Cabazitaxel, Cerbrium, Cerebrolysin, Dacepton/Apomorphine, Dexemedetomidine, Docetaxel, Fulvestrant, MemoProve, Oxytocin, Paclitaxel, Pemetrexed, Tachyben, Terlipressin, Trabectedin, Eribulin -
Product Pemetrexed EVER Pharma
Pemetrexed is an antineoplastic chemotherapy drug. It is used in the treatment of malignant mesothelioma and locally advanced or metastatic nonsquamous non-small cell lung cancer. - Available as a ready to dilute liquid formulation – does not require reconstitution from powder saving time and costs. It ca... -
Product Terlipressin EVER Pharma
- Ready to use product - for immediate use without reconstitution - Available in vials - safer and more convenient than ampoules - 5ml and new 10ml presentation covering initial and maintenance dose ranges - Additional indication - for Hepato-renal syndrome type I -
Product Trabectedin EVER Pharma: 0.25mg + 1.0mg - LYO Vial
- Available in 2 presentations – providing greater flexibility and convenience when preparing patient specific doses - All vial sizes come in CytoWrap® – for safer handling and transportation Description: Trabectedin is an antineoplastic chemotherapy drug. It is indicated as a monotherapy for the treatme... -
Product Azacitidine EVER Pharma
Azacitidine is a cytotoxic hypomethylating chemical analogue of cytidine used in the treatment of myelodysplastic syndromes.
Azacitidine EVER Pharma is available in both the standard 100 mg vial size and a new 150 mg vial size aligned to the most common patient doses to minimize waste... -
Product Bortezomib EVER Pharma
Bortezomib is a protease inhibitor indicated for the treatment of progressive or untreated multiple myeloma, and mantle cell lymphoma.
Bortezomib EVER Pharma is provided as a ready to useformulation for subcutaneous injection (SC), and afterdilution for intravenous injection. -
Product Cabazitaxel EVER Pharma
Cabazitaxel is a third-generation antineoplastic taxane and was the fi rst therapy to show a survival benefi t for the treatment of patients with docetaxel-refractory mCRPC.
Cabazitaxel EVER Pharma is provided as a single vial, ready to dilute formulation and is available in vial sizes&nbs... -
Product Dexmedetomidine EVER Pharma
Dexmedetomidine is a highly selective alpha-2 adrenergic receptor notable for its ability to provide sedation without the risk of respiratory depression.
The first Dexmedetomidine in Europe indicated for both ICU and procedural sedation.
EVER Pharma Resources (6)
-
News EVER Pharma receives EU approval for a liquid ready to use Bortezomib formulation
EVER Pharma is pleased to announce EU-wide approval of Bortezomib for the treatment of patients with multiple myeloma and mantle cell lymphoma -
Technical Data EVER Pharma: Contract Manufacturing Services
EVER Pharma offers a wide range of services which includes clinical and commercial supply services.
It offers a high level of expertise to support the manufacturing of clinical products from phase I to phase III; prepare and complete PPQ manufacturing and support commercial product for worldwide markets.
We are specialized in the manufacture of complex, injectable substances with a special focus on:
Handling of highly active substances (e.g. narcotics, hormones, cytotoxics)Low-oxygen formulationsCrystal suspensionsOily solutionsWe also offer our customers support for development, regulation, production, and testing:
Validation, analytical services, and clinical batch manufacturingCommercial manufacture of sterile dosage formsSecondary packaging and storageOptimization of formulations and processesAnalytical testing of sterile dosage formsStability testTechnical advice
Contact us for more information. -
Technical Data EVER Pharma: Product list of speciality injectables
EVER Pharma's products include: Atosiban -- 7.5 mg/ml Solution for Injection/InfusionAzacitidine -- 25 mg/ml Powder for Suspension for InjectionCabazitaxel -- 10 mg/ml - Solution for InfusionCerebrolysin® -- 215.2 mg/ml - Solution for Infusion Concentrate for Solution for InfusionDacepton (Apomorphine) -- 5 mg/ml & 10 mg/ml - Solution for Injection/InfusionDexmedetomidine -- 100 µg/ml - Concentrate for Solution for InfusionDocetaxel -- 20 mg/ml - Concentrate for injectionFulvestrant -- 50 mg/ml - Ready to use pre-filled syringeOxytocin -- 5 IU/ml & 10 IU/ml - Solution for Injection/InfusionPaclitaxel-- 6 mg/ml - Concentrate for InjectionPemetrexed -- 25 mg/ml - Concentrate for Solution for InfusionTerlipressin -- 0.17 mg/ml - Solution for Injection/Infusion -
Brochure EVER Pharma - CMO Services
Overview on CMO services offered by EVER Pharma -
Brochure EVER Pharma - Product List
Overview on products offered by EVER Pharma -
Brochure Cabazitaxel EVER Pharma
45mg/4.5ml + 50mg/5.0ml + 60mg/6ml
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance